PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences, Moscow, Russia.\', \'Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.\', \'Department of Biology, Lomonosov Moscow State University, Moscow, Russia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/22221751.2021.1971569
?:hasPublicationType
?:journal
  • Emerging microbes & infections
is ?:pmid of
?:pmid
?:pmid
  • 34427172
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all